Brief: Kiora Pharmaceuticals To Implement 1-For-40 Reverse Split
26/09/2022 13:40
Sept 26 (Reuters) - Kiora Pharmaceuticals Inc KPRX.O :
* KIORA PHARMACEUTICALS TO IMPLEMENT 1-FOR-40 REVERSE SPLIT
* KIORA PHARMACEUTICALS INC - ON NASDAQ CAPITAL MARKET,
TRADING ON
A SPLIT-ADJUSTED BASIS IS EXPECTED TO BEGIN ON TUESDAY,
SEPTEMBER 27, 2022
Further company coverage: KPRX.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Kiora Pharmaceuticals
See all newsKiora Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Kiora Pharmaceuticals, Inc. expected to post a loss of 62 cents a share - Earnings Preview
Brief: Kiora Pharmaceuticals Inc - Enters Securities Purchase Agreement On April 3, 2026 - SEC Filing
Kiora Pharmaceuticals posts 2025 net loss as expenses rise
Brief: Kiora Pharmaceuticals Files For Mixed Shelf Offering Of Up To $100 Million- SEC Filing